Rapid7 Vulnerability & Exploit Database

Cisco IOS-XR: CVE-2022-20655: Multiple Cisco Products CLI Command Injection Vulnerability

Free InsightVM Trial No Credit Card Necessary
2024 Attack Intel Report Latest research by Rapid7 Labs
Back to Search

Cisco IOS-XR: CVE-2022-20655: Multiple Cisco Products CLI Command Injection Vulnerability

Severity
7
CVSS
(AV:L/AC:L/Au:S/C:C/I:C/A:C)
Published
01/19/2022
Created
01/10/2023
Added
01/09/2023
Modified
01/22/2025

Description

A vulnerability in the implementation of the CLI on a device that is running ConfD could allow an authenticated, local attacker to perform a command injection attack. The vulnerability is due to insufficient validation of a process argument on an affected device. An attacker could exploit this vulnerability by injecting commands during the execution of this process. A successful exploit could allow the attacker to execute arbitrary commands on the underlying operating system with the privilege level of ConfD, which is commonly root.

Solution(s)

  • update-xros

insightVM

Advanced vulnerability management analytics and reporting.
Key Features
  • Lightweight Endpoint Agent
  • Live Dashboards
  • Real Risk Prioritization
  • IT-Integrated Remediation Projects
  • Cloud, Virtual, and Container Assessment
  • Integrated Threat Feeds
  • Easy-to-Use RESTful API
  • Automation-Assisted Patching
  • Automated Containment
Free InsightVM Trial View All Features

With Rapid7 live dashboards, I have a clear view of all the assets on my network, which ones can be exploited, and what I need to do in order to reduce the risk in my environment in real-time. No other tool gives us that kind of value and insight.

– Scott Cheney, Manager of Information Security, Sierra View Medical Center

;